Labcorp Holdings Inc. (BVMF:L1CA34)
Brazil
· Delayed Price · Currency is BRL 358.66
+13.66 (3.96%)
At close: Nov 21, 2025
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.56B USD in the quarter ending September 30, 2025, with 8.58% growth. This brings the company's revenue in the last twelve months to $13.77B, up 8.28% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.77B
Revenue Growth
+8.28%
P/S Ratio
1.58
Revenue / Employee
$196.65K
Employees
70,000
Market Cap
115.94B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
| Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |